Ensign Peak Advisors Portfolio holdings
AUM
$58.4B
1-Year Return
23.83%
This Quarter Return
+8.8%
1 Year Return
+23.83%
3 Year Return
+106.64%
5 Year Return
+193.2%
10 Year Return
–
AUM
$46.2B
AUM Growth
+$1.83B
(+4.1%)
Cap. Flow
-$279M
Cap. Flow
% of AUM
-0.6%
Top 10 Holdings %
Top 10 Hldgs %
24.86%
Holding
1,810
New
24
Increased
1,140
Reduced
325
Closed
37
Top Buys
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$101M |
| 2 |
Eli Lilly
LLY
|
+$99.8M |
| 3 |
Kinder Morgan
KMI
|
+$96.2M |
| 4 |
UnitedHealth
UNH
|
+$75.9M |
| 5 |
Palo Alto Networks
PANW
|
+$65.5M |
Top Sells
| 1 |
iShares Russell 2000 ETF
IWM
|
+$179M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$154M |
| 3 |
Microsoft
MSFT
|
+$120M |
| 4 |
Charles Schwab
SCHW
|
+$116M |
| 5 |
Bank of America
BAC
|
+$96.7M |
Sector Composition
| 1 | Technology | 22.9% |
| 2 | Healthcare | 18.49% |
| 3 | Financials | 11.85% |
| 4 | Consumer Discretionary | 9.1% |
| 5 | Industrials | 7.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Simmons First National
SFNC
$2.97B
| $927K | ﹤0.01% |
52,980
+5,900
| +13% | +$103K |
|
1302
Tri Pointe Homes
TPH
$3.07B
| $925K | ﹤0.01% |
36,524
+1,800
| +5% | +$45.6K |
|
1303
Resideo Technologies
REZI
$5.39B
| $924K | ﹤0.01% |
50,560
| – | – |
|
1304
Xerox
XRX
$456M
| $923K | ﹤0.01% |
59,960
| – | – |
|
1305
Antero Midstream
AM
$8.79B
| $922K | ﹤0.01% |
87,930
+25,950
| +42% | +$272K |
|
1306
Columbia Sportswear
COLM
$3.01B
| $920K | ﹤0.01% |
10,200
+1,850
| +22% | +$167K |
|
1307
Credit Acceptance
CACC
$5.8B
| $920K | ﹤0.01% |
2,110
-562
| -21% | -$245K |
|
1308
Carter's
CRI
$1.04B
| $919K | ﹤0.01% |
12,775
+450
| +4% | +$32.4K |
|
1309
Tandem Diabetes Care
TNDM
$836M
| $919K | ﹤0.01% |
22,620
+50
| +0.2% | +$2.03K |
|
1310
Ambarella
AMBA
$3.56B
| $918K | ﹤0.01% |
11,860
+750
| +7% | +$58.1K |
|
1311
Extreme Networks
EXTR
$2.96B
| $917K | ﹤0.01% |
47,960
| – | – |
|
1312
ChargePoint
CHPT
$235M
| $916K | ﹤0.01% |
4,377
+148
| +3% | +$31K |
|
1313
InterDigital
IDCC
$7.7B
| $916K | ﹤0.01% |
12,568
| – | – |
|
1314
Enovis
ENOV
$1.74B
| $915K | ﹤0.01% |
17,106
| – | – |
|
1315
ServisFirst Bancshares
SFBS
$4.6B
| $915K | ﹤0.01% |
16,745
+3,250
| +24% | +$178K |
|
|
EFC
1316
Ellington Financial
EFC
$1.36B
| $913K | ﹤0.01% |
74,800
+7,450
| +11% | +$91K |
|
1317
Pebblebrook Hotel Trust
PEB
$1.36B
| $913K | ﹤0.01% |
65,020
| – | – |
|
1318
Minerals Technologies
MTX
$1.98B
| $912K | ﹤0.01% |
15,101
+2,250
| +18% | +$136K |
|
1319
LCI Industries
LCII
$2.47B
| $912K | ﹤0.01% |
8,299
+550
| +7% | +$60.4K |
|
1320
Blue Owl Capital
OWL
$12.1B
| $912K | ﹤0.01% |
82,290
+9,500
| +13% | +$105K |
|
1321
Ingevity
NGVT
$2.08B
| $912K | ﹤0.01% |
12,745
+650
| +5% | +$46.5K |
|
1322
Dana Inc
DAN
$2.73B
| $910K | ﹤0.01% |
60,489
+5,150
| +9% | +$77.5K |
|
1323
Verint Systems
VRNT
$1.23B
| $907K | ﹤0.01% |
24,350
+4,150
| +21% | +$155K |
|
1324
First Financial Bancorp
FFBC
$2.48B
| $906K | ﹤0.01% |
41,610
+4,900
| +13% | +$107K |
|
1325
Revolution Medicines
RVMD
$7.56B
| $905K | ﹤0.01% |
41,790
| – | – |
|